Healthcare provider profile · identity verified

John James Glogowski, NP-BC

Nurse Practitioner · CHICOPEE, MA · NPI 1588930994

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	749	226
Lisinopril	Lisinopril	436	126
Amlodipine Besylate	Amlodipine Besylate	331	91
Levothyroxine Sodium	Levothyroxine Sodium	286	68
Omeprazole	Omeprazole	281	70
Gabapentin	Gabapentin	268	51
Losartan Potassium	Losartan Potassium	240	69
Metoprolol Succinate	Metoprolol Succinate	238	57
Rosuvastatin Calcium	Rosuvastatin Calcium	234	64
Hydrochlorothiazide	Hydrochlorothiazide	209	54
Metformin Hcl	Metformin Hcl	204	61
Albuterol Sulfate Hfa	Albuterol Sulfate	197	51
Ezetimibe	Ezetimibe	143	38
Trazodone Hcl	Trazodone Hcl	125	31
Jardiance	Empagliflozin	103	35
Ibuprofen	Ibuprofen	101	24
Simvastatin	Simvastatin	97	26
Buspirone Hcl	Buspirone Hcl	91	26
Sertraline Hcl	Sertraline Hcl	91	26
Eliquis	Apixaban	87	21
Metformin Hcl Er	Metformin Hcl	86	24
Pantoprazole Sodium	Pantoprazole Sodium	86	26
Metoprolol Tartrate	Metoprolol Tartrate	83	21
Ozempic	Semaglutide	83	17
Famotidine	Famotidine	78	17
Tramadol Hcl	Tramadol Hcl	78	20
Furosemide	Furosemide	77	20
Atenolol	Atenolol	72	20
Pravastatin Sodium	Pravastatin Sodium	71	18
Trulicity	Dulaglutide	70	13
Fluticasone Propionate	Fluticasone Propionate	68	27
Duloxetine Hcl	Duloxetine Hcl	66	15
Clonazepam	Clonazepam	64	11
Pregabalin	Pregabalin	63	13
Montelukast Sodium	Montelukast Sodium	62	15
Meloxicam	Meloxicam	59	22
Lorazepam	Lorazepam	58	21
Warfarin Sodium	Warfarin Sodium	54	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	17
Tamsulosin Hcl	Tamsulosin Hcl	51	13
Tizanidine Hcl	Tizanidine Hcl	51	16
Ventolin Hfa	Albuterol Sulfate	49	15
Fluoxetine Hcl	Fluoxetine Hcl	47	13
Bupropion Xl	Bupropion Hcl	45	13
Prednisone	Prednisone	45	36
Baclofen	Baclofen	43	suppressed
Irbesartan	Irbesartan	42	14
Fenofibrate	Fenofibrate	41	suppressed
Clonidine Hcl	Clonidine Hcl	40	suppressed
Allopurinol	Allopurinol	37	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	11
Paroxetine Hcl	Paroxetine Hcl	36	11
Citalopram Hbr	Citalopram Hydrobromide	35	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	12
Pioglitazone Hcl	Pioglitazone Hcl	33	11
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	31	12
Sildenafil Citrate	Sildenafil Citrate	31	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Farxiga	Dapagliflozin Propanediol	29	suppressed
Potassium Chloride	Potassium Chloride	29	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	28	suppressed
Finasteride	Finasteride	28	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Glipizide	Glipizide	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Carvedilol	Carvedilol	23	suppressed
Celecoxib	Celecoxib	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Amoxicillin	Amoxicillin	22	11
Incruse Ellipta	Umeclidinium Bromide	22	suppressed
Valsartan	Valsartan	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	14
Clobetasol Propionate	Clobetasol Propionate	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Prazosin Hcl	Prazosin Hcl	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Cephalexin	Cephalexin	20	14
Glipizide Er	Glipizide	19	suppressed
Loperamide	Loperamide Hcl	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Azithromycin	Azithromycin	18	17
Synthroid	Levothyroxine Sodium	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Ketoconazole	Ketoconazole	17	11
Linzess	Linaclotide	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Nystatin	Nystatin	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	15	suppressed
Belsomra	Suvorexant	14	suppressed
Colesevelam Hcl	Colesevelam Hcl	14	suppressed
Ibu	Ibuprofen	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	14	suppressed
Temazepam	Temazepam	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Diazepam	Diazepam	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Wegovy	Semaglutide	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Penicillin V Potassium	Penicillin V Potassium	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error